Figure 5 shows a continuous significant increase in the host serum cytokine profiles of (A) IL-15, (B) IL-18, and (C) M-CSF up to day 25 post-implantation of MiaPaCa-2-eGFP cells, followed by a gradual decrease when the tumor begins to grow at day 30. The gene discussed is IL15; the disease is neoplasm.